In January, we reported on billionaire investor Antonio Gracias’ bid to take control of embattled MDMA drug developer Lykos Therapeutics. Now, Gracias appears to be teaming up with an unlikely co-investor. Psychedelic Alpha understands that the Musk associate and DOGE advisor is joined by an even deeper-pocketed individual: Sir Christopher Hohn.
